Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 12/20 | 0.50 |
| ▸ | PRMT3 | O60678 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31037443 | 0.91 | NAMPT (0.43) | NAMPTPRMT3LMNAC3AR1 | |
| SCHEMBL31037293 | 0.81 | LMNA (0.48) | NAMPTPRMT3LMNANPC1MAPT | |
| SCHEMBL31037286 | 0.81 | LMNA (0.48) | NAMPTPRMT3LMNANPC1MAPT | |
| SCHEMBL31037254 | 0.80 | NAMPT (0.46) | NAMPTPRMT3LMNANPC1MAPT | |
| SCHEMBL31037302 | 0.79 | NAMPT (0.51) | NAMPTPRMT3LMNANPC1MAPT | |
| SCHEMBL31037328 | 0.78 | NAMPT (0.46) | NAMPTPRMT3LMNARAB9A | |
| SCHEMBL31037483 | 0.78 | NAMPT (0.47) | NAMPTPRMT3LMNA | |
| SCHEMBL31037498 | 0.78 | LMNA (0.44) | NAMPTPRMT3LMNARAB9A | |
| SCHEMBL31037335 | 0.77 | KEAP1 (0.44) | NAMPTPRMT3LMNA | |
| SCHEMBL31037357 | 0.75 | PAX8 (0.42) | NPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4663628-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Samjin Pharmaceutical Co., Ltd. (KR) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024166024-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 삼진제약주식회사 | 2024-08-15 | — | — | WO | disclosed |